Procaps Group Reports First Quarter 2023 Results
Constant Currency Net Revenues Increased 10% Quarter-over-Quarter in 1Q23, and 22% increase in Adjusted EBITDA, With Strong Demand of RX…
Pharmaceuticals, Biotechnology and Life Sciences
Constant Currency Net Revenues Increased 10% Quarter-over-Quarter in 1Q23, and 22% increase in Adjusted EBITDA, With Strong Demand of RX…
– Compassionate use enables treating physicians in Germany to request access to investigational TransCon PTH (palopegteriparatide) for eligible adult patients…
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST MDxHealth Announces its Extraordinary General…
JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population Presented at ASCO 2023 – Toripalimab plus chemotherapy resulted in a 37%…
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions…
Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers, including seeking key FDA approvals…
Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL, presented at an oral session…
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the…
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc.,…
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform…